Mineralys Therapeutics Inc (MLYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 192,403 | 84,657 | 31,479 | 18,725 | 2,943 |
| Operating Income | -192,403 | -84,657 | -31,479 | -18,725 | -2,943 |
| Interest Expense | 0 | 0 | 0 | 0 | 115 |
| Other Income | 14,593 | 12,759 | 1,680 | -683 | -368 |
| Pre-tax Income | -177,810 | -71,898 | -29,799 | -19,408 | -3,426 |
| Net Income Continuous | -177,810 | -71,898 | -29,799 | -19,408 | -3,426 |
| Net Income | $-177,810 | $-71,898 | $-29,799 | $-19,408 | $-3,426 |
| EPS Basic Total Ops | -3.66 | -1.99 | -5.77 | -3.89 | -0.74 |
| EPS Basic Continuous Ops | -3.66 | -1.99 | -5.77 | -3.89 | -0.74 |
| EPS Diluted Total Ops | -3.66 | -1.99 | -5.77 | -3.89 | -0.74 |
| EPS Diluted Continuous Ops | -3.66 | -1.99 | -5.77 | -3.89 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -3.66 | -1.99 | -5.77 | -3.89 | N/A |
| EBITDA(a) | $-192,360 | $-84,657 | $-31,479 | $-18,725 | $-2,943 |